Drugs Made in America Acquisition (DMAAU) Competitors $10.60 0.00 (0.00%) As of 09/11/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock DMAAU vs. ONCHU, ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, and ANSCUShould you be buying Drugs Made in America Acquisition stock or one of its competitors? The main competitors of Drugs Made in America Acquisition include 1RT Acquisition (ONCHU), A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), and Agriculture & Natural Solutions Acquisition (ANSCU). These companies are all part of the "trading" industry. Drugs Made in America Acquisition vs. Its Competitors 1RT Acquisition A SPAC III Acquisition AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition 1RT Acquisition (NASDAQ:ONCHU) and Drugs Made in America Acquisition (NASDAQ:DMAAU) are both investment offices industry companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership. Which has better valuation & earnings, ONCHU or DMAAU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio1RT AcquisitionN/AN/AN/AN/AN/ADrugs Made in America AcquisitionN/AN/AN/AN/AN/A Is ONCHU or DMAAU more profitable? Company Net Margins Return on Equity Return on Assets 1RT AcquisitionN/A N/A N/A Drugs Made in America Acquisition N/A N/A N/A Does the media prefer ONCHU or DMAAU? In the previous week, 1RT Acquisition and 1RT Acquisition both had 1 articles in the media. Drugs Made in America Acquisition's average media sentiment score of 1.91 beat 1RT Acquisition's score of 1.89 indicating that Drugs Made in America Acquisition is being referred to more favorably in the news media. Company Overall Sentiment 1RT Acquisition Very Positive Drugs Made in America Acquisition Very Positive SummaryDrugs Made in America Acquisition beats 1RT Acquisition on 1 of the 1 factors compared between the two stocks. Get Drugs Made in America Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAAU and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DMAAU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DMAAU vs. The Competition Export to ExcelMetricDrugs Made in America AcquisitionInvestment Offices IndustryFinance SectorNASDAQ ExchangeMarket CapN/A$193.86M$12.60B$10.15BDividend YieldN/AN/A5.41%4.61%P/E RatioN/AN/A245.6025.92Price / SalesN/AN/A31.2483.33Price / CashN/A36,966.8922.1259.91Price / BookN/AN/A2.316.29Net IncomeN/A-$160K$1.01B$270.85M7 Day Performance2.42%0.00%1.04%3.36%1 Month PerformanceN/A0.11%3.13%6.41%1 Year PerformanceN/A8.21%543.62%28.26% Drugs Made in America Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DMAAUDrugs Made in America AcquisitionN/A$10.60flatN/AN/A$0.00N/A0.002Positive NewsONCHU1RT AcquisitionN/A$10.43-0.1%N/AN/A$0.00N/A0.002ASPCUA SPAC III AcquisitionN/A$10.99+5.7%N/AN/A$0.00N/A0.00N/AGap UpAGBAWAGBA GroupN/A$0.04-0.5%N/A-82.9%$0.00$38.55M0.00152AGNCPAGNC InvestmentN/A$25.32+0.4%N/A+4.2%$0.00$496M0.0050News CoveragePositive NewsDividend IncreaseShort Interest ↓AGNCOAGNC InvestmentN/A$25.64+0.5%N/A+2.0%$0.00$496M0.0050News CoverageDividend IncreaseAGNCNAGNC InvestmentN/A$25.81-0.1%N/A-1.0%$0.00$496M0.0050News CoverageDividend IncreaseShort Interest ↓AGNCMAGNC InvestmentN/A$25.07+0.0%N/A-0.7%$0.00$496M0.0050Dividend IncreaseShort Interest ↓High Trading VolumeAGNCLAGNC InvestmentN/A$25.140.0%N/A+3.4%$0.00$496M0.0050Dividend AnnouncementShort Interest ↓ANSCWAgriculture & Natural Solutions AcquisitionN/A$0.22-6.1%N/A+37.4%$0.00N/A0.00N/AANSCUAgriculture & Natural Solutions AcquisitionN/A$11.03-5.3%N/AN/A$0.00N/A0.00N/A Related Companies and Tools Related Companies 1RT Acquisition Competitors A SPAC III Acquisition Competitors AGBA Group Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors Agriculture & Natural Solutions Acquisition Competitors Agriculture & Natural Solutions Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DMAAU) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made in America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made in America Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DMAAU Stock Alerts